Cosmos Health Inc. (COSM)
0.68
0.07 (11.29%)
At close: Jan 14, 2025, 3:59 PM
0.67
-1.02%
Pre-market Jan 15, 2025, 04:12 AM EST
undefined% (undefined)
| Bid | 0.66 |
| Market Cap | 15.75M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.45 |
| PE Ratio (ttm) | -0.28 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.69 |
| Volume | 948,031 |
| Avg. Volume (20D) | 238,332 |
| Open | 0.62 |
| Previous Close | 0.61 |
| Day's Range | 0.62 - 0.69 |
| 52-Week Range | 0.47 - 1.58 |
| Beta | undefined |
About COSM
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as...
Next Earnings Release
Cosmos Health Inc. is scheduled to release its earnings on Aug 5, 2025,
before market opens.
Analysts project revenue of $14.50M, reflecting a -8.45% YoY shrinking and earnings per share of -0.11, making a -93.64% decrease YoY.
Analysts project revenue of $14.50M, reflecting a -8.45% YoY shrinking and earnings per share of -0.11, making a -93.64% decrease YoY.
1 month ago ·
Source
+11.13%
Cosmos Health shares are trading higher after the ...
Unlock content with
Pro Subscription
4 months ago ·
Source
+17.76%
Cosmos Health shares are trading higher after the company announced that, pursuant to its agreement with Virax Biolabs, it continues to hold the rights to distribute mpox virus real-time PCR detection kits, with exclusive distribution rights in Greece and Cyprus, and non-exclusive distribution rights across Europe.
